Home  >  News
  Vertex's Orkambi receives European approval to treat children with CF aged 2 to 5 years old with most common form of disease,   January 22, 2019
  Focus on personalized cancer treatment drives the Pharmacogenomics (PGx) labelling of oncology drugs,   January 21, 2019
  Taiho Oncology and Servier present data on Lonsurf (trifluridine/tipiracil) at ASCO 2019 Gastrointestinal Cancers Symposium (ASCO GI),   January 21, 2019
  ISPE releases Good Practice Guide: Technology Transfer 3rd Edition,   January 21, 2019
  Therachon gets US FDA orphan drug status for apraglutide for short bowel syndrome treatment,   January 19, 2019
  US FDA grants orphan drug designation to Bridge Biotherapeutics' BBT-877 in IPF,   January 19, 2019
  Janssen expands clinical development of guselkumab into ulcerative colitis,   January 19, 2019
  US FDA EMDA committee split over Sanofi-Lexicon diabetes drug, sotagliflozin,   January 19, 2019
  US FDA seeks additional data from Actelion's sNDA for Opsumit to treat CTEPH,   January 18, 2019
  US FDA's BRUDA committee recommends approval of Evenity to treat postmenopausal women with osteoporosis,   January 18, 2019
  Teva Pharma receives US FDA approval of generic Sabril to treat complex partial seizures,   January 18, 2019
  US FDA accepts Roche's sBLA for Tecentriq in combo with Abraxane and carboplatin to treat metastatic NSCLC,   January 18, 2019
  TerrAscend Completes Acquisition of Grander Distribution, a US Hemp-Derived Products Company,   January 17, 2019
  Abbott to buy medical device company, Cephea Valve Technologies,   January 17, 2019
  Eisai, Purdue Pharma submit NDA for insomnia disorder treatment lemborexant with US FDA,   January 17, 2019
  bioLIVE China to lead devpt of bio-pharma tech in Asia,   January 17, 2019
  Arfinn Med introduces physician portal for medical cannabis treatments & efficacies,   January 16, 2019
  US FDA approves Exelixis' Cabometyx tablets for previously treated HCC,   January 16, 2019
  EMA issues revised guideline aims to strengthen global approach to develop new antibacterial medicines for 6-month public consultation,   January 16, 2019
  Bristol-Myers receives European approval for Opdivo plus low dose Yervoy to treat patients with intermediate- and advanced RCC,   January 15, 2019

Copyright © 2016 Saffron Media Pvt. Ltd |